Search Results 1551-1560 of 14993 for Hepatitis C

1. A Study To Assess The Safety And Efficacy Of LB-P8 In Patients With PSC - Mayo Clinic

   ... hepatitis, iron overload syndrome, Wilson disease, nonalcoholic ... Additionally, positive serology for hepatitis B surface antigen (HBsAg), hepatitis C ...

2. Phase 3 Study of Obeticholic Acid Evaluating Clinical Outcomes in Patients With Primary Biliary Cirrhosis

   Participation eligibility · Hepatitis C virus infection · Active Hepatitis B infection; however, subjects who have seroconverted (hepatitis B surface antigen and ...

3. Phase 2a, Dose-ranging Study With PF-05221304 In Nonalcoholic Fatty Liver Disease (NAFLD) - Mayo Clinic

   Positive for Hepatitis B, Hepatitis C, or Human Deficiency Virus; Severe Renal Impairment; Contraindications for MRI. Participating Mayo Clinic locations. Study ...

4. Primary sclerosing cholangitis (PSC) - Doctors and departments - Mayo Clinic

   tocellular carcinoma, Cirrhosis, Hepatitis C, Hepatitis B, Nonalcoholic fatty liver disease, Primary biliary cholangitis, Cholangiocarcinoma, Primary ...

5. A Study Comparing Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Patients with Chronic Lymphocytic Leukemia - Mayo Clinic

   ... hepatitis C;; Serologic status reflecting active hepatitis B or C infection. Patients with hepatitis B or C infection may be eligible if viral loads are ...

6. A Study Of Investigational Immunotherapy To Determine The Safety And Effectiveness Of Nivolumab And Daratumumab, With Or Without Pomalidomide And Dexamethasone, In Patients With Relapsed/Refractory Hematologic Malignancies - Mayo Clinic

   Seropositive for hepatitis C (except in the setting of a sustained virologic response [SVR], defined as aviremia at least 12 weeks after completion of antiviral ...

7. A Study Of Subcutaneous Daratumumab Versus Active Monitoring In Participants With High-Risk Smoldering Multiple Myeloma - Mayo Clinic

   Known to be seropositive for hepatitis C (except in the setting of a sustained virologic response [SVR], defined as aviremia at least 12 weeks after completion ...

8. El minuto de Mayo Clinic El abecé de la hepatitis Video Audio Vivien Williams En EE. UU., alrededor de 5.3 millones de personas

   “Pese a que no existe vacuna contra la hepatitis C, en los últimos años, hay terapias muy eficaces para tratarla”. Vivien Williams. Para la Red Informativa de ...

9. Study To Assess Enobosarm (GTx-024) In Postmenopausal Women With Stress Urinary Incontinence - Mayo Clinic

   Chronic hepatitis; Hepatic cirrhosis; Evidence of active infection with hepatitis B or hepatitis C; History of human immunodeficiency virus (HIV) infection ...

10. A Study Of Vutrisiran (ALN-TTRSC02) In Patients With Hereditary Transthyretin Amyloidosis (HATTR Amyloidosis) - Mayo Clinic

    Has known human immunodeficiency virus (HIV), hepatitis C virus (HCV) or hepatitis B virus (HBV) infection. Received an experimental drug within 30 days of ...